Analyst Reco. Knight Therapeutics Inc.

Equities

Delayed Toronto S.E. Other stock markets 09:50:17 2024-04-26 am EDT			5-day change	1st Jan Change
5.72 ^CAD	+0.53%		0.00%	+10.21%

Mar. 22	Knight Therapeutics Price Target Raised to $7 at RBC	MT
Mar. 21	Knight Therapeutics Reports Fourth Quarter Results	MT

Knight Therapeutics Price Target Raised to $7 at RBC	Mar. 22	MT
National Bank Downgrades Knight Therapeutics to Sector Perform, Cuts Price Target to $6, on "Soft" Outlook	23-03-24	MT
Knight Therapeutics Hold Rating Maintained by Stifel GMP as Q2 Results Beat Forecasts; Price Target Raised to C$5.40	22-08-12	MT

No results for this search